1b8k Citations

The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding site.

Protein Sci 8 2589-97 (1999)
Related entries: 1b8m, 1b98

Cited: 45 times
EuropePMC logo PMID: 10631974

Abstract

The neurotrophins are growth factors that are involved in the development and survival of neurons. Neurotrophin release by a target tissue results in neuron growth along the neurotrophin concentration gradient, culminating in the eventual innervation of the target tissue. These activities are mediated through trk cell surface receptors. We have determined the structures of the heterodimer formed between brain-derived neurotrophic factor (BDNF) and neurotrophin 4 (NT4), as well as the structure of homodimer of NT4. We also present the structure of the Neurotrophin 3 homodimer, which is refined to higher resolution than previously published. These structures provide the first views of the architecture of the NT4 protomer. Comparison of the surface of a model of the BDNF homodimer with the structures of the neurotrophin homodimers reveals common features that may be important in the binding between the neurotrophins and their receptors. In particular, there exists an analogous region on the surface of each neurotrophin that is likely to be involved in trk receptor binding. Variations in sequence on the periphery of this common region serve to confer trk receptor specificity.

Articles - 1b8k mentioned but not cited (2)



Reviews citing this publication (13)

  1. Neurotrophins: roles in neuronal development and function. Huang EJ, Reichardt LF. Annu Rev Neurosci 24 677-736 (2001)
  2. Trk receptors: roles in neuronal signal transduction. Huang EJ, Reichardt LF. Annu Rev Biochem 72 609-642 (2003)
  3. Nerve growth factor signaling, neuroprotection, and neural repair. Sofroniew MV, Howe CL, Mobley WC. Annu Rev Neurosci 24 1217-1281 (2001)
  4. Principles of design and biological approaches for improving the selectivity of cochlear implant electrodes. O'Leary SJ, Richardson RR, McDermott HJ. J Neural Eng 6 055002 (2009)
  5. Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor. Eibl JK, Strasser BC, Ross GM. Neurochem Int 61 1266-1275 (2012)
  6. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Khalin I, Alyautdin R, Kocherga G, Bakar MA. Int J Nanomedicine 10 3245-3267 (2015)
  7. Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy. Pramanik S, Sulistio YA, Heese K. Mol Neurobiol 54 7401-7459 (2017)
  8. Hydrogels as delivery systems for spinal cord injury regeneration. Silva D, Sousa RA, Salgado AJ. Mater Today Bio 9 100093 (2021)
  9. Neuroprotective and restorative effects of the brain-derived neurotrophic factor in retinal diseases. Afarid M, Torabi-Nami M, Zare B. J Neurol Sci 363 43-50 (2016)
  10. Cell guidance ligands, receptors and complexes - orchestrating signalling in time and space. Rozbesky D, Jones EY. Curr Opin Struct Biol 61 79-85 (2020)
  11. Nanoscaffolds in promoting regeneration of the peripheral nervous system. Aijie C, Xuan L, Huimin L, Yanli Z, Yiyuan K, Yuqing L, Longquan S. Nanomedicine (Lond) 13 1067-1085 (2018)
  12. Antidepressant-like effects of trophic factor receptor signaling. Sathyanesan M, Newton SS. Front Mol Neurosci 15 958797 (2022)
  13. C3-Symmetric Ligands in Drug Design: When the Target Controls the Aesthetics of the Drug. Antonijevic M, Rochais C, Dallemagne P. Molecules 28 679 (2023)

Articles citing this publication (30)

  1. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, Pan G, Gurney AL, de Vos AM, Starovasnik MA. EMBO J 20 5332-5341 (2001)
  2. Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma. Pasutto F, Matsumoto T, Mardin CY, Sticht H, Brandstätter JH, Michels-Rautenstrauss K, Weisschuh N, Gramer E, Ramdas WD, van Koolwijk LM, Klaver CC, Vingerling JR, Weber BH, Kruse FE, Rautenstrauss B, Barde YA, Reis A. Am J Hum Genet 85 447-456 (2009)
  3. Design of potent peptide mimetics of brain-derived neurotrophic factor. O'Leary PD, Hughes RA. J Biol Chem 278 25738-25744 (2003)
  4. From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Géral C, Angelova A, Lesieur S. Pharmaceutics 5 127-167 (2013)
  5. Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex with neurotrophin-4/5. Banfield MJ, Naylor RL, Robertson AG, Allen SJ, Dawbarn D, Brady RL. Structure 9 1191-1199 (2001)
  6. Molecular and structural insight into proNGF engagement of p75NTR and sortilin. Feng D, Kim T, Ozkan E, Light M, Torkin R, Teng KK, Hempstead BL, Garcia KC. J Mol Biol 396 967-984 (2010)
  7. BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels? O'Sullivan E, Barrett E, Grenham S, Fitzgerald P, Stanton C, Ross RP, Quigley EM, Cryan JF, Dinan TG. Benef Microbes 2 199-207 (2011)
  8. In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival. Guerzoni LP, Nicolas V, Angelova A. Pharm Res 34 492-505 (2017)
  9. Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities. Qian MD, Zhang J, Tan XY, Wood A, Gill D, Cho S. J Neurosci 26 9394-9403 (2006)
  10. Phylogenesis of brain-derived neurotrophic factor (BDNF) in vertebrates. Tettamanti G, Cattaneo AG, Gornati R, de Eguileor M, Bernardini G, Binelli G. Gene 450 85-93 (2010)
  11. Design of a conformationally defined and proteolytically stable circular mimetic of brain-derived neurotrophic factor. Fletcher JM, Morton CJ, Zwar RA, Murray SS, O'Leary PD, Hughes RA. J Biol Chem 283 33375-33383 (2008)
  12. Novel monocyclic and bicyclic loop mimetics of brain-derived neurotrophic factor. Fletcher JM, Hughes RA. J Pept Sci 12 515-524 (2006)
  13. Artificial cells drive neural differentiation. Toparlak ÖD, Zasso J, Bridi S, Serra MD, Macchi P, Conti L, Baudet ML, Mansy SS. Sci Adv 6 eabb4920 (2020)
  14. Therapeutic time window for the neuroprotective effects of NGF when administered after focal cerebral ischemia. Yang JP, Liu HJ, Yang H, Feng PY. Neurol Sci 32 433-441 (2011)
  15. Directed evolution of brain-derived neurotrophic factor for improved folding and expression in Saccharomyces cerevisiae. Burns ML, Malott TM, Metcalf KJ, Hackel BJ, Chan JR, Shusta EV. Appl Environ Microbiol 80 5732-5742 (2014)
  16. Three-tier regulation of cell number plasticity by neurotrophins and Tolls in Drosophila. Foldi I, Anthoney N, Harrison N, Gangloff M, Verstak B, Nallasivan MP, AlAhmed S, Zhu B, Phizacklea M, Losada-Perez M, Moreira M, Gay NJ, Hidalgo A. J Cell Biol 216 1421-1438 (2017)
  17. [Design and synthesis of dipeptide mimetics of brain-derived neurotrophic factor]. Gudasheva TA, Tarasiuk AV, Pomogaĭbo SV, Logvinov IO, Povarnina PIu, Antipova TA, Seredenin SB. Bioorg Khim 38 280-290 (2012)
  18. Nanoparticles-induced apoptosis of human airway epithelium is mediated by proNGF/p75NTR signaling. Chakraborty S, Castranova V, Perez MK, Piedimonte G. J Toxicol Environ Health A 80 53-68 (2017)
  19. Peptides derived from the solvent-exposed loops 3 and 4 of BDNF bind TrkB and p75(NTR) receptors and stimulate neurite outgrowth and survival. Fobian K, Owczarek S, Budtz C, Bock E, Berezin V, Pedersen MV. J Neurosci Res 88 1170-1181 (2010)
  20. Trk Receptors and Neurotrophin Cross-Interactions: New Perspectives Toward Manipulating Therapeutic Side-Effects. Haddad Y, Adam V, Heger Z. Front Mol Neurosci 10 130 (2017)
  21. Cyclic amino acid linkers stabilizing key loops of brain derived neurotrophic factor. Baeza JL, de la Torre BG, Santiveri CM, Almeida RD, García-López MT, Gerona-Navarro G, Jaffrey SR, Jiménez MÁ, Andreu D, González-Muñiz R, Martín-Martínez M. Bioorg Med Chem Lett 22 444-448 (2012)
  22. Dimeric mimetic of BDNF loop 4 promotes survival of serum-deprived cell through TrkB-dependent apoptosis suppression. Zainullina LF, Vakhitova YV, Lusta AY, Gudasheva TA, Seredenin SB. Sci Rep 11 7781 (2021)
  23. Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor. Paoletti F, de Chiara C, Kelly G, Covaceuszach S, Malerba F, Yan R, Lamba D, Cattaneo A, Pastore A. Front Mol Biosci 3 83 (2016)
  24. Generation of a high-fidelity antibody against nerve growth factor using library scanning mutagenesis and validation with structures of the initial and optimized Fab-antigen complexes. La Porte SL, Eigenbrot C, Ultsch M, Ho WH, Foletti D, Forgie A, Lindquist KC, Shelton DL, Pons J. MAbs 6 1059-1068 (2014)
  25. Pharmaceutical Characterization of Tropomyosin Receptor Kinase B-Agonistic Antibodies on Human Induced Pluripotent Stem (hiPS) Cell-Derived Neurons. Traub S, Stahl H, Rosenbrock H, Simon E, Florin L, Hospach L, Hörer S, Heilker R. J Pharmacol Exp Ther 361 355-365 (2017)
  26. Weak conservation of structural features in the interfaces of homologous transient protein-protein complexes. Sudha G, Singh P, Swapna LS, Srinivasan N. Protein Sci 24 1856-1873 (2015)
  27. Decellularized equine carotid artery layers as matrix for regenerated neurites of spiral ganglion neurons. Yilmaz-Bayraktar S, Schwieger J, Scheper V, Lenarz T, Böer U, Kreienmeyer M, Torrente M, Doll T. Int J Artif Organs 43 332-342 (2020)
  28. Comparative insights using the molecular homology model of BDNF (Brain derived neurotrophic factor) of Varanus komodoensis and the known NGF (Nerve growth factor) structure of Naja atra. Verma A, Sharma DK, Sarma R, Chetia H, Saikia J. Bioinformation 9 755-758 (2013)
  29. Antidepressant-like Effects of BDNF and NGF Individual Loop Dipeptide Mimetics Depend on the Signal Transmission Patterns Associated with Trk. Mezhlumyan AG, Tallerova AV, Povarnina PY, Tarasiuk AV, Sazonova NM, Gudasheva TA, Seredenin SB. Pharmaceuticals (Basel) 15 284 (2022)
  30. Development of a rapid, high-efficiency, scalable refold for neurotrophin-4. Buckley JJ, Hoeltzli SD, Johnson GV. Biotechnol Appl Biochem 56 27-34 (2010)


Related citations provided by authors (1)

  1. Heterodimers of the Neurotrophic Factors: Formation, Isolation, and Differential Stability. Radziejewski C, Robinson RC Biochemistry 32 13350- (1993)